Epidemiology of Stone Disease

Overview

Journal Urol Clin North Am

Specialty Urology

Date 2007 Aug 7

PMID 17678980

Citations 131

Authors

Gary C Curhan

Affiliations

Soon will be listed here.

Abstract

Epidemiology has improved our understanding and management of stone disease. Epidemiologic studies, by quantifying patterns and burden of disease, have helped identify risk factors, leading to changes in clinical practice and providing insights into pathophysiologic processes related to stone formation. Because nephrolithiasis is a complex disease, an understanding of the epidemiology, particularly the interactions among different factors, may help lead to approaches that reduce the risk of stone formation.

Citing Articles

Associations between dietary fatty acids and kidney stones.

Tan N, Zhang Y Sci Rep. 2025; 15(1):2500.

PMID: 39833367 PMC: 11747447. DOI: 10.1038/s41598-025-86850-x.

The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021.

EClinicalMedicine. 2024; 78:102924.

PMID: 39640943 PMC: 11618031. DOI: 10.1016/j.eclinm.2024.102924.

Improving Guideline Adherence for the Radiological Investigation of Acute Renal Colic: A Two-Cycle Quality Improvement Project.

Ali M, Abay B, Ali A, Saad M, Al-Ghazawi M, Kamel H Cureus. 2024; 16(11):e73472.

PMID: 39529919 PMC: 11554377. DOI: 10.7759/cureus.73472.

Metoclopramide for analgesia in renal colic: a narrative systematic review.

Tabner A, Ganesh A, Hobbs L, Ponna N, Reed M, Fakis A BMC Urol. 2024; 24(1):240.

PMID: 39487461 PMC: 11529211. DOI: 10.1186/s12894-024-01598-2.

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.

McCormick N, Yokose C, Lu N, Wexler D, Avina-Zubieta J, De Vera M BMJ. 2024; 387():e080035.

PMID: 39477370 PMC: 11524131. DOI: 10.1136/bmj-2024-080035.

References

Holmes R, Kennedy M . Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int. 2000; 57(4):1662-7. DOI: 10.1046/j.1523-1755.2000.00010.x. View

Siener R, Honow R, Voss S, Seidler A, Hesse A . Oxalate content of cereals and cereal products. J Agric Food Chem. 2006; 54(8):3008-11. DOI: 10.1021/jf052776v. View

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U . Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346(2):77-84. DOI: 10.1056/NEJMoa010369. View

Kramer H, Curhan G . The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002; 40(1):37-42. DOI: 10.1053/ajkd.2002.33911. View

Stamatelou K, Francis M, Jones C, Nyberg L, Curhan G . Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63(5):1817-23. DOI: 10.1046/j.1523-1755.2003.00917.x. View

Traxer O, Huet B, Poindexter J, Pak C, Pearle M . Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003; 170(2 Pt 1):397-401. DOI: 10.1097/01.ju.0000076001.21606.53. View

Kramer H, Choi H, Atkinson K, Stampfer M, Curhan G . The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int. 2003; 64(3):1022-6. DOI: 10.1046/j.1523-1755.2003.t01-2-00171.x. View

Hesse A, Brandle E, Wilbert D, Kohrmann K, Alken P . Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003; 44(6):709-13. DOI: 10.1016/s0302-2838(03)00415-9. View

Curhan G, Willett W, Knight E, Stampfer M . Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004; 164(8):885-91. DOI: 10.1001/archinte.164.8.885. View

10.

Resnick M, Pridgen D, Goodman H . Genetic predisposition to formation of calcium oxalate renal calculi. N Engl J Med. 1968; 278(24):1313-8. DOI: 10.1056/NEJM196806132782403. View

11.

LEMANN Jr J, Piering W, Lennon E . Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. N Engl J Med. 1969; 280(5):232-7. DOI: 10.1056/NEJM196901302800502. View

12.

Coe F . Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978; 13(5):418-26. DOI: 10.1038/ki.1978.60. View

13.

Robertson W, Peacock M, Hodgkinson A . Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. J Chronic Dis. 1979; 32(6):469-76. DOI: 10.1016/0021-9681(79)90107-3. View

14.

Johnson C, Wilson D, OFallon W, Malek R, Kurland L . Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979; 16(5):624-31. DOI: 10.1038/ki.1979.173. View

15.

Johansson G, Backman U, Danielson B, Fellstrom B, Ljunghall S, Wikstrom B . Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol. 1980; 124(6):770-4. DOI: 10.1016/s0022-5347(17)55655-4. View

16.

Hiatt R, Dales L, Friedman G, Hunkeler E . Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982; 115(2):255-65. DOI: 10.1093/oxfordjournals.aje.a113297. View

17.

Muldowney F, Freaney R, Moloney M . Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982; 22(3):292-6. DOI: 10.1038/ki.1982.168. View

18.

Bataille P, CHARRANSOL G, Gregoire I, Daigre J, Coevoet B, Makdassi R . Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol. 1983; 130(2):218-23. DOI: 10.1016/s0022-5347(17)51073-3. View

19.

Ettinger B, Tang A, Citron J, Livermore B, Williams T . Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315(22):1386-9. DOI: 10.1056/NEJM198611273152204. View

20.

Larsson L, Tiselius H . Hyperoxaluria. Miner Electrolyte Metab. 1987; 13(4):242-50. View